130 related articles for article (PubMed ID: 2983909)
1. Effects of high-dose and low-dose naloxone on plasma ACTH in patients with ACTH hypersecretion.
Deuss U; Allolio B; Kaulen D; Fischer H; Winkelmann W
Clin Endocrinol (Oxf); 1985 Mar; 22(3):273-9. PubMed ID: 2983909
[TBL] [Abstract][Full Text] [Related]
2. The effect of sodium valproate in Cushing's disease, Nelson's syndrome and Addison's disease.
Reincke M; Allolio B; Kaulen D; Jaursch-Hancke C; Winkelmann W
Klin Wochenschr; 1988 Aug; 66(15):686-9. PubMed ID: 2845188
[TBL] [Abstract][Full Text] [Related]
3. Profound amplification of secretory-burst mass and anomalous regularity of ACTH secretory process in patients with Nelson's syndrome compared with Cushing's disease.
van Aken MO; Pereira AM; van den Berg G; Romijn JA; Veldhuis JD; Roelfsema F
Clin Endocrinol (Oxf); 2004 Jun; 60(6):765-72. PubMed ID: 15163342
[TBL] [Abstract][Full Text] [Related]
4. Effects of valproic acid, naloxone and hydrocortisone in Nelson's syndrome and cushing's disease.
Elias AN; Gwinup G; Valenta LJ
Clin Endocrinol (Oxf); 1981 Aug; 15(2):151-4. PubMed ID: 6273025
[TBL] [Abstract][Full Text] [Related]
5. Lack of ACTH lowering effect of sodium valproate in patients with ACTH hypersecretion.
Loli P; Berselli ME; Frascatani F; Muratori F; Tagliaferri M
J Endocrinol Invest; 1984 Apr; 7(2):93-6. PubMed ID: 6327800
[TBL] [Abstract][Full Text] [Related]
6. Plasma ACTH and cortisol responses to TRF, vasopressin or hypoglycemia in cushing's disease and nelson's syndrome.
Krieger DT; Luria M
J Clin Endocrinol Metab; 1977 Feb; 44(2):361-8. PubMed ID: 190254
[TBL] [Abstract][Full Text] [Related]
7. Corticotropin-releasing hormone (CRH) stimulation in Nelson's syndrome: response of adrenocorticotropin secretion to pulse injection and continuous infusion of CRH.
Oldfield EH; Schulte HM; Chrousos GP; Gold PW; Benker G; Peterson RE; Cutler GB; Loriaux DL
J Clin Endocrinol Metab; 1986 May; 62(5):1020-6. PubMed ID: 3007552
[TBL] [Abstract][Full Text] [Related]
8. Effects of a met-enkephalin analog on adrenocorticotropin (ACTH), growth hormone, and prolactin in patients with ACTH hypersecretion.
Allolio B; Winkelmann W; Hipp FX; Kaulen D; Mies R
J Clin Endocrinol Metab; 1982 Jul; 55(1):1-7. PubMed ID: 6281297
[TBL] [Abstract][Full Text] [Related]
9. A correlative study between cortisol and ACTH in Cushing's disease following bilateral adrenalectomy and in Nelson's syndrome.
Kasperlik-Załuska A; Niegowska E; Migdalska B; Jeske W; Zieliński M
Endokrynol Pol; 1992; 43(3):314-21. PubMed ID: 1345571
[TBL] [Abstract][Full Text] [Related]
10. Hyperprolactinemia in Cushing's disease and Nelson's syndrome.
Yamaji T; Ishibashi M; Teramoto A; Fukushima T
J Clin Endocrinol Metab; 1984 May; 58(5):790-5. PubMed ID: 6323516
[TBL] [Abstract][Full Text] [Related]
11. Gel chromatographic characterization of immunoreactive adrenocorticotropin in patients with ACTH hypersecretion.
Reincke M; Allolio B; Deuss U; Winkelmann W
Klin Wochenschr; 1989 Nov; 67(21):1096-100. PubMed ID: 2555628
[TBL] [Abstract][Full Text] [Related]
12. The effect of the long-acting somatostatin analogue SMS 201-995 on ACTH secretion in Nelson's syndrome and Cushing's disease.
Lamberts SW; Uitterlinden P; Klijn JM
Acta Endocrinol (Copenh); 1989 Jun; 120(6):760-6. PubMed ID: 2543178
[TBL] [Abstract][Full Text] [Related]
13. Effects of sodium-valproate administration on plasma ACTH levels in patients with ACTH hypersecretion.
Ambrosi B; Bochicchio D; Riva E; Faglia G
J Endocrinol Invest; 1983 Aug; 6(4):305-6. PubMed ID: 6315806
[TBL] [Abstract][Full Text] [Related]
14. The effect of sodium valproate on plasma ACTH and cortisol concentrations in Cushing's disease and Nelson's syndrome.
Kasperlik-Załuska A; Drac-Kaniewska J; Migdalska B; Jeske W; Wiśniewska-Woźniak T
Endokrynol Pol; 1988; 39(5):245-52. PubMed ID: 2855625
[No Abstract] [Full Text] [Related]
15. The effect of low-dose naloxone infusion on plasma ACTH and LH in patients with Cushing's and Addison's diseases.
Moreira AC; Foss MC; Iazigi N; Verissimo JM
Horm Metab Res; 1988 Apr; 20(4):230-4. PubMed ID: 2840381
[TBL] [Abstract][Full Text] [Related]
16. Nyctohemeral variation and suppressibility of plasma ACTH in various stages of Cushing's disease.
Cook DM; Kendall JW; Allen JP; Lagerquist LG
Clin Endocrinol (Oxf); 1976 Jul; 5(4):303-12. PubMed ID: 183922
[TBL] [Abstract][Full Text] [Related]
17. Corticotropin-releasing factor test in normal subjects and patients with hypothalamic-pituitary-adrenal disorders.
Nakahara M; Shibasaki T; Shizume K; Kiyosawa Y; Odagiri E; Suda T; Yamaguchi H; Tsushima T; Demura H; Maeda T
J Clin Endocrinol Metab; 1983 Nov; 57(5):963-8. PubMed ID: 6311867
[TBL] [Abstract][Full Text] [Related]
18. Effect of desmopressin on ACTH and cortisol secretion in states of ACTH excess.
Colombo P; Passini E; Re T; Faglia G; Ambrosi B
Clin Endocrinol (Oxf); 1997 Jun; 46(6):661-8. PubMed ID: 9274696
[TBL] [Abstract][Full Text] [Related]
19. A study of patients with Nelson's syndrome.
Pereira MA; Halpern A; Salgado LR; Mendonça BB; Nery M; Liberman B; Streeten DH; Wajchenberg BL
Clin Endocrinol (Oxf); 1998 Oct; 49(4):533-9. PubMed ID: 9876353
[TBL] [Abstract][Full Text] [Related]
20. Ineffectiveness of rosiglitazone therapy in Nelson's syndrome.
Munir A; Song F; Ince P; Walters SJ; Ross R; Newell-Price J
J Clin Endocrinol Metab; 2007 May; 92(5):1758-63. PubMed ID: 17311852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
